Hybridoma Cell Line D8H21, Monoclonal Antibody to the Specific Peptide-MHC Class II Complex
Hybridoma Cell Line D8H21, as described in Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13856-61 and developed in the laboratory of Dr. Ronald Germain.
Potential Commercial Applications: | Competitive Advantages: |
|
|
Inventors:
Ronald Germain (NIAID) ➽ more inventions...
Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 1948-039)
Publications:
Zhong G, et al. PMID 9391117
Licensing Contact:
Daniel Lee, J.D.
Email: daniel.lee5@nih.gov
Phone: 301-761-6327
OTT Reference No: B-021-1999-0
Updated: Dec 4, 2017